Center for Scientific Review; Notice of Closed Meetings

Published date10 March 2021
Citation86 FR 13721
Record Number2021-04950
SectionNotices
CourtNational Institutes Of Health
Federal Register, Volume 86 Issue 45 (Wednesday, March 10, 2021)
[Federal Register Volume 86, Number 45 (Wednesday, March 10, 2021)]
                [Notices]
                [Pages 13721-13722]
                From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
                [FR Doc No: 2021-04950]
                -----------------------------------------------------------------------
                DEPARTMENT OF HEALTH AND HUMAN SERVICES
                National Institutes of Health
                Center for Scientific Review; Notice of Closed Meetings
                 Pursuant to section 10(d) of the Federal Advisory Committee Act, as
                amended, notice is hereby given of the following meetings.
                 The meetings will be closed to the public in accordance with the
                provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
                U.S.C., as amended. The grant applications and the discussions could
                disclose confidential trade secrets or commercial property such as
                patentable material, and personal information concerning individuals
                associated with the grant applications, the disclosure of which would
                constitute a clearly unwarranted invasion of personal privacy.
                 Name of Committee: Center for Scientific Review Special Emphasis
                Panel; Member Conflict: Neuropsychiatric Disorders.
                 Date: April 6, 2021.
                 Time: 1:00 p.m. to 5:00 p.m.
                 Agenda: To review and evaluate grant applications.
                 Place: National Institutes of Health, 6701 Rockledge Drive,
                Bethesda, MD 20892 (Virtual Meeting).
                 Contact Person: Jenny Raye Browning, Ph.D., Scientific Review
                Officer, Center for Scientific Review, National Institutes of
                Health, 6701 Rockledge Drive, Rm. 5207, Bethesda, MD 20892, (301)
                402-8197, [email protected].
                 Name of Committee: Center for Scientific Review Special Emphasis
                Panel; Special Topics: Emerging Imaging Technologies in
                Neuroscience.
                 Date: April 7, 2021.
                 Time: 9:00 a.m. to 2:00 p.m.
                 Agenda: To review and evaluate grant applications.
                 Place: National Institutes of Health, Rockledge II, 6701
                Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
                 Contact Person: Sharon S. Low, Ph.D., Scientific Review Officer,
                Center for Scientific Review, National Institutes of Health, 6701
                Rockledge Drive, Room 5104, MSC 5104, Bethesda, MD, 20892-5104, 301-
                237-1487, [email protected].
                 Name of Committee: Center for Scientific Review Special Emphasis
                Panel; RFA-RM-20-013 and 020: NIH Transformative and Emergency
                Transformative Research (R01) Awards Review.
                 Date: April 7-8, 2021.
                 Time: 9:00 a.m. to 6:00 p.m.
                 Agenda: To review and evaluate grant applications.
                 Place: National Institutes of Health, Rockledge II, 6701
                Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
                 Contact Person: James J. Li, Ph.D., Scientific Review Officer,
                Center for Scientific Review, National Institutes of Health, 6701
                Rockledge Drive, Room 5148,
                [[Page 13722]]
                MSC 7849, Bethesda, MD 20892, 301-806-8065, [email protected].
                 Name of Committee: Center for Scientific Review Special Emphasis
                Panel; Small Business Hematology and Vascular Biology.
                 Date: April 7, 2021.
                 Time: 9:30 a.m. to 2:00 p.m.
                 Agenda: To review and evaluate grant applications.
                 Place: National Institutes of Health, Rockledge II, 6701
                Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
                 Contact Person: Larry Pinkus, Ph.D., Scientific Review Officer,
                Center for Scientific Review, National Institutes of Health, 6701
                Rockledge Drive, Room 4132, MSC 7802, Bethesda, MD 20892, (301) 435-
                1214, [email protected].
                 Name of Committee: Center for Scientific Review Special Emphasis
                Panel; Member Conflict: Topics in Metabolism.
                 Date: April 7, 2021.
                 Time: 10:00 a.m. to 4:00 p.m.
                 Agenda: To review and evaluate grant applications.
                 Place: National Institutes of Health, Rockledge II, 6701
                Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
                 Contact Person: Latha Meenalochana Malaiyandi, Ph.D., Scientific
                Review Officer, Center for Scientific Review, National Institutes of
                Health, 6701 Rockledge Drive, Room 812Q, Bethesda, MD 20892, (301)
                435-1999, [email protected].
                 Name of Committee: Center for Scientific Review Special Emphasis
                Panel; AIDS and AIDS Related Research.
                 Date: April 7, 2021.
                 Time: 10:30 a.m. to 5:00 p.m.
                 Agenda: To review and evaluate grant applications.
                 Place: National Institutes of Health, Rockledge II, 6701
                Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
                 Contact Person: Alok Mulky, Ph.D., Scientific Review Officer,
                Center for Scientific Review, National Institutes of Health, 6701
                Rockledge Drive, Room 4203, Bethesda, MD 20892, (301) 435-3566,
                [email protected].
                 Name of Committee: Center for Scientific Review Special Emphasis
                Panel; Member Conflict: Radiation Therapeutics and Biology.
                 Date: April 7, 2021.
                 Time: 12:00 p.m. to 4:00 p.m.
                 Agenda: To review and evaluate grant applications.
                 Place: National Institutes of Health, Rockledge II, 6701
                Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
                 Contact Person: Laura Asnaghi, Ph.D., Scientific Review Officer,
                National Institutes of Health, Center for Scientific Review, 6701
                Rockledge Drive, Room 6200, MSC 7804, Bethesda, MD 20892, (301) 443-
                1196, [email protected].
                 Name of Committee: Center for Scientific Review Special Emphasis
                Panel; Member Conflict: Cancer Biology.
                 Date: April 7, 2021.
                 Time: 12:30 p.m. to 4:30 p.m.
                 Agenda: To review and evaluate grant applications.
                 Place: National Institutes of Health, Rockledge II, 6701
                Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
                 Contact Person: Juraj Bies, Ph.D., Scientific Review Officer,
                Center for Scientific Review, National Institutes of Health, 6701
                Rockledge Drive, Rm. 4158, MSC 7806, Bethesda, MD 20892, 301 435
                1256, [email protected].
                (Catalogue of Federal Domestic Assistance Program Nos. 93.306,
                Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
                93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
                National Institutes of Health, HHS)
                 Dated: March 4, 2021.
                Melanie J. Pantoja,
                Program Analyst, Office of Federal Advisory Committee Policy.
                [FR Doc. 2021-04950 Filed 3-9-21; 8:45 am]
                BILLING CODE 4140-01-P
                

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT